A patient in Vienna, Austria was admitted to a local hospital. The 45 year old woman had a 7 day history of cough, weakness, myalgia, fever, and dyspnoea. She also had a 4 day history of nausea and diarrhea. The next day after admittance, her condition worsened, and the patient was put on a ventilator. […]

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Jonathan Javitt, CEO of NeuroRx. Dr Javitt discusses how NeuroRx is working in collaboration with Relief Therapeutics on Aviptadil, a synthetic version of vasoactive intestinal peptide, and a potential treatment of COVID-19 related respiratory […]

Mei Mei Hu, JD, co-founder and co-CEO and Peter Diamandis, MD, co-founder and vice chairman at COVAXX, a division of United Biomedical, discuss UB-612, which could be the first multitope peptide-based vaccine for COVID-19 based on a commercially proven platform that has shown promising efficacy in animals and is safe and scalable. In September 2020 […]